Medical News

RSS

Phase III efficacy trial of two AIDS vaccine candidates shows promise

The International AIDS Vaccine Initiative (IAVI) greeted with excitement today’s announcement by the U.S. Military HIV Research Program and the Thai Ministry of Public Health that, according to an initial analysis, a prime-boost combination of two AIDS vaccine candidates has shown partial efficacy in a phase III efficacy trial in Thailand. The prime-boost combination appeared to be about 31% effective at preventing infection with HIV.

24 Sep 2009

Online portal for parents of children with disabilities

United Cerebral Palsy (UCP), today announced the launch of My Child Without Limits (MyChildWithoutLimits.org), UCP's pioneering initiative that provides parents of children with disabilities an online resource with critical information that also connects parents to a vital social network of parents of newly diagnosed children ages 0 to 5.

24 Sep 2009

COMPARE trial results demonstrate higher efficacy of XIENCE V stent system

Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS(R) Liberte Paclitaxel-Eluting Coronary Stent System (TAXUS).

24 Sep 2009

TRUEresult store brand blood glucose monitoring system more accurate than name brand products: Study

Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, today announced that a new study has shown that its TRUEresult® store brand blood glucose monitoring system is comparable to the performance of more expensive name brand systems.

24 Sep 2009

H1N1 slows growth in US industries and GDP

H1N1 influenza could slow growth in key industries and stall already-weak GDP growth in the third and fourth quarters of 2009, says a health economist in the University of Alabama at Birmingham (UAB) School of Business.

24 Sep 2009

KORE Telematics certifies MedApps telehealth solutions for use on its network

American Telemedicine Association Mid-Year Meeting—KORE Telematics, the world’s largest digital wireless services provider specializing in machine-to-machine (M2M) communications, today announced that MedApps telehealth solutions are now certified for use on the KORE network.

24 Sep 2009

Women usually tightlipped about bladder problems

Women may be known as the more talkative sex, but when it comes to a certain sensitive health topic, their lips are sealed, according to a new "Bladder Talk" survey of 780 women aged 35 and older in North America (U.S. and Canada) sponsored by TENA(R), the worldwide leader in the management of bladder protection, and conducted by Harris Interactive.

24 Sep 2009

ThromboGenics completes enrollment for MIVI-TRUST clinical trial

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the US Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.

24 Sep 2009

Allocate Software and NHS Professionals renew contract for StaffBank application

Allocate Software plc, the leading provider of workforce optimisation solutions, and NHS Professionals, the largest provider of flexible staff managed services to the NHS, are pleased to announce the renewal of a contract for the provision of the StaffBank application.

24 Sep 2009

Polycom's scalable solutions for the healthcare industry

Polycom, Inc., the global leader in telepresence, video and voice communication solutions, is making it easier and more cost-effective for hospitals and other healthcare organizations to deploy and scale telehealth and telemedicine networks. Through an enhanced, highly scalable solution, Polycom allows healthcare organizations to easily and securely extend visual communication capabilities outside of their private networks to a broader group of partner hospitals, community clinics and physicians.

24 Sep 2009

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

CEL-SCI Corporation (NYSE AMEX: CVM), a developer of vaccines and therapeutics for the treatment of infectious diseases and a late-stage oncology company, announced today that it has hired a full-service Clinical Research Organization (CRO) with an office in the Washington, D.C./Baltimore area to support its conduct of the upcoming clinical trial of its investigational LEAPS-H1N1 treatment.

24 Sep 2009

New method found for the treatment of pancreatic cancer

For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.

24 Sep 2009

Rasagiline slows the rate of Parkinson's disease progression

Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report today in The New England Journal of Medicine that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.

24 Sep 2009

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.

24 Sep 2009

Governor Howard Dean to sign copies of his new book and discuss about health care reform

Governor Howard Dean will be in Philadelphia, PA and New York City on Thursday, September 24th to discuss health care reform and sign copies of his new book, Howard Dean's Prescription for Real Healthcare Reform (www.deanshealthcare.com).

24 Sep 2009

Update on Cerezyme and Fabrazyme supply from Genzyme Corporation

Genzyme Corporation (NASDAQ: GENZ) today provided an update on its progress to restore supplies of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase beta) for patients worldwide and revised its 2009 revenue guidance for these products.

24 Sep 2009

Clinical Site Services launches new website providing clinical trial information

Clinical Site Services (CSS), a leader in patient enrollment solutions for the clinical research industry, announces the launch of its comprehensive website,http://www.MyClinicalTrial.com, which is focused on advancing the significance of clinical research.

24 Sep 2009

Hsp-27 protein: An indicator of prostate cancer progression

In the largest study of its kind, the international team of pathologists studied an initial 4,000 prostate cancer patients over a period of 15 years to further understanding into the natural progression of the disease and how it should be managed. The research, published in the British Journal of Cancer, could be used to develop a blood test to distinguish between aggressive and non-aggressive forms of prostate cancer.

24 Sep 2009

Obama addresses U.N. General Assembly, calls for 'new era of engagement'

In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).

24 Sep 2009

The Kosciusko County Community Foundation receives a $7M grant to establish an orthopedics initiative

The Kosciusko County Community Foundation (KCCF) and BioCrossroads announced that a $7 million grant, made by Lilly Endowment Inc. to KCCF, will support the establishment of OrthoWorx, a Warsaw-based, industry, community and education initiative to advance and support growth and innovation within the region's uniquely concentrated, globally significant orthopedics device sector.

24 Sep 2009